224 related articles for article (PubMed ID: 19127489)
1. The relationship between dysglycemia and cognitive dysfunction.
Cukierman-Yaffee T
Curr Opin Investig Drugs; 2009 Jan; 10(1):70-4. PubMed ID: 19127489
[TBL] [Abstract][Full Text] [Related]
2. Altered glycemia and brain-update and potential relevance to the aging brain.
McCall AL
Neurobiol Aging; 2005 Dec; 26 Suppl 1():70-5. PubMed ID: 16198444
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in the brain: an old-age or new-age problem?
Williamson R; McNeilly A; Sutherland C
Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
[TBL] [Abstract][Full Text] [Related]
4. [Cerebral complications of diabetes mellitus].
Aszalós Z
Orv Hetil; 2007 Dec; 148(50):2371-6. PubMed ID: 18055361
[TBL] [Abstract][Full Text] [Related]
5. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.
Sima AA; Kamiya H; Li ZG
Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in patients with type 2 diabetes.
Reijmer YD; van den Berg E; Ruis C; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2010 Oct; 26(7):507-19. PubMed ID: 20799243
[TBL] [Abstract][Full Text] [Related]
7. [The impact of dysglycemia on brain function in children with type 1 diabetes mellitus].
Pańkowska E
Med Wieku Rozwoj; 2012; 16(1):5-9. PubMed ID: 22516768
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
Wessels AM; Scheltens P; Barkhof F; Heine RJ
Eur J Pharmacol; 2008 May; 585(1):88-96. PubMed ID: 18396273
[TBL] [Abstract][Full Text] [Related]
9. Links between cognitive impairment in insulin resistance: an explanatory model.
Convit A
Neurobiol Aging; 2005 Dec; 26 Suppl 1():31-5. PubMed ID: 16246463
[TBL] [Abstract][Full Text] [Related]
10. Insulin and neurodegenerative disease: shared and specific mechanisms.
Craft S; Watson GS
Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains.
Zhang T; Pan BS; Zhao B; Zhang LM; Huang YL; Sun FY
Neuroscience; 2009 Jul; 161(4):1045-56. PubMed ID: 19376202
[TBL] [Abstract][Full Text] [Related]
12. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
Calvo-Ochoa E; Arias C
Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies.
Bourdel-Marchasson I; Lapre E; Laksir H; Puget E
Diabetes Metab; 2010 Jun; 36(3):173-81. PubMed ID: 20472485
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes mellitus and cognition: is there a link?].
Barrou Z; Lemaire A; Boddaert J; Verny M
Psychol Neuropsychiatr Vieil; 2008 Sep; 6(3):189-98. PubMed ID: 18786878
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, dysglycemia and cognitive dysfunction.
Cukierman-Yaffe T
Diabetes Metab Res Rev; 2014 Jul; 30(5):341-5. PubMed ID: 24339052
[TBL] [Abstract][Full Text] [Related]
16. Searching for the origin of brain dysfunction in diabetic children: going back to the beginning.
Ryan CM
Pediatr Diabetes; 2008 Dec; 9(6):527-30. PubMed ID: 19067890
[No Abstract] [Full Text] [Related]
17. Vascular risk factors and cognitive decline among elderly male twins.
Gotkine M
Neurology; 2007 May; 68(21):1871; author reply 1871. PubMed ID: 17515556
[No Abstract] [Full Text] [Related]
18. Diabetes, hyperglycemia and the management of cerebrovascular disease.
Haratz S; Tanne D
Curr Opin Neurol; 2011 Feb; 24(1):81-8. PubMed ID: 21124220
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and cognitive dysfunction.
Ma L; Wang J; Li Y
Clin Chim Acta; 2015 Apr; 444():18-23. PubMed ID: 25661087
[TBL] [Abstract][Full Text] [Related]
20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
